2 most recent filings and news items mentioning NKGEN. Updated every 60 seconds.
OfferingJun 2, 2026Positive
NKGen Biotech amended its secured convertible loan agreement to receive $2.42 million in additional funding from AlpineBrook Capital, with new warrant issuance. The financing extension demonstrates continued investor support for the biotech company's capital needs.
View filing at SEC.gov →
OfferingMay 21, 2026Positive
NKGen Biotech and its operating subsidiary amended their secured convertible loan agreement to receive an additional $412,500 in funding from AlpineBrook Capital GP I Limited, with the lender receiving additional consideration shares and warrants. The capital injection suggests t
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.